1 study on Ml-iap curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study demonstrates the immense potential of computational peptide engineering to rapidly design and optimize therapeutic candidates for challenging diseases like melanoma. The significant improvements in binding …
Free, no account — handy when you're working with Ml-iap.